ATE485302T1 - Neue estrogene, herstellbar durch erhitzung von konjugierten estrogenen unter erhöhter feuchtigkeit - Google Patents

Neue estrogene, herstellbar durch erhitzung von konjugierten estrogenen unter erhöhter feuchtigkeit

Info

Publication number
ATE485302T1
ATE485302T1 AT04008154T AT04008154T ATE485302T1 AT E485302 T1 ATE485302 T1 AT E485302T1 AT 04008154 T AT04008154 T AT 04008154T AT 04008154 T AT04008154 T AT 04008154T AT E485302 T1 ATE485302 T1 AT E485302T1
Authority
AT
Austria
Prior art keywords
estrogens
heating
new
under increased
produced
Prior art date
Application number
AT04008154T
Other languages
English (en)
Inventor
Edward N Hill
Thomas Leonard
Robert R Whittle
Original Assignee
Barr Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Barr Lab Inc filed Critical Barr Lab Inc
Application granted granted Critical
Publication of ATE485302T1 publication Critical patent/ATE485302T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT04008154T 2003-04-04 2004-04-02 Neue estrogene, herstellbar durch erhitzung von konjugierten estrogenen unter erhöhter feuchtigkeit ATE485302T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/407,509 US6992075B2 (en) 2003-04-04 2003-04-04 C(14) estrogenic compounds

Publications (1)

Publication Number Publication Date
ATE485302T1 true ATE485302T1 (de) 2010-11-15

Family

ID=32850668

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04008154T ATE485302T1 (de) 2003-04-04 2004-04-02 Neue estrogene, herstellbar durch erhitzung von konjugierten estrogenen unter erhöhter feuchtigkeit

Country Status (7)

Country Link
US (1) US6992075B2 (de)
EP (1) EP1464650B1 (de)
AT (1) ATE485302T1 (de)
CA (1) CA2462998C (de)
DE (1) DE602004029633D1 (de)
ES (1) ES2351881T3 (de)
PL (1) PL1464650T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040167111A1 (en) * 1998-04-15 2004-08-26 Michael Oettel Pharmaceutical preparations for treating side effects during and/or after GnRHa therapy
EP1168912B1 (de) 1999-03-23 2007-05-09 Hibernation Therapeutics Limited Stoppen, schützen und konservieren von organen
US20060034941A1 (en) * 2002-12-23 2006-02-16 Global Cardiac Solutions Pty Ltd Organ preconditioning, arrest, protection, preservation and recovery
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
WO2006042172A2 (en) * 2004-10-09 2006-04-20 The Regents Of The University Of Michigan Gender differences in experimental aortic aneurysm formation
EP1853272A1 (de) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Zusammensetzungen aus unkonjugierten östrogenen und anwendungsverfahren dafür
WO2007076144A2 (en) * 2005-12-27 2007-07-05 Duramed Pharmaceuticals, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
JP2009538834A (ja) 2006-05-29 2009-11-12 ハイバーネイション セラピューティクス リミテッド 組織維持の改善
ES2539762T3 (es) 2006-07-25 2015-07-03 Hibernation Therapeutics, A Kf Llc Tratamiento de traumatismos
WO2008106724A1 (en) 2007-03-02 2008-09-12 Hibernation Therapeutics Limited Transplants
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
CN101808509A (zh) * 2007-07-25 2010-08-18 低温药理有限公司 改进的器官保护、维护和康复
US20090234024A1 (en) * 2008-02-04 2009-09-17 Hooman Shadnia Estrogenic compounds, process for their production and pharmaceutical uses thereof
WO2015006831A1 (en) 2013-07-17 2015-01-22 Hts Therapeutics Pty Ltd A method for reducing, inflammation, coagulation and adhesions

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959322A (en) * 1960-09-22 1976-05-25 Herchel Smith Synthesis of 13-alkyl-gon-4-ones
US3230142A (en) 1963-03-25 1966-01-18 Upjohn Co Oral contraceptive compositions and methods
NL6615481A (de) 1966-11-02 1968-05-03
US3487152A (en) 1967-02-07 1969-12-30 Hoffmann La Roche Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances
US3568828A (en) 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
US3591688A (en) 1969-08-22 1971-07-06 American Home Prod Method of preventing ovulation and composition therefor
US3639600A (en) 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3608077A (en) * 1969-11-13 1971-09-21 Syntex Corp Stabilization of metal steroid alcohol sulfates
US3795734A (en) 1970-04-20 1974-03-05 American Home Prod Cyclic regimen of hormone administration for contraception
US3733407A (en) 1971-08-25 1973-05-15 Syntex Corp Menopause treatment
US3836651A (en) 1972-02-22 1974-09-17 Biolog Concepts Inc Novel oral contraceptive combination
US3969502A (en) 1972-04-14 1976-07-13 Schering Aktiengesellschaft Method for contraception by the administration of sequential contraceptive preparations
DE2310963A1 (de) 1972-04-14 1974-09-05 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
US3932635A (en) 1972-04-24 1976-01-13 Syntex Corporation Novel cyclic progestogen-interrupted estrogen oral contraceptive regimens
US3942641A (en) 1972-05-05 1976-03-09 Syntex Corporation Dispensing packages containing novel cyclic progestogen-interrupted estrogen oral contraceptive regimens
GB1399162A (en) 1972-06-29 1975-06-25 Schering Ag 6-keto-delta1,3,5-10-steroids and process for the manufacture of 6-keto-delta1,3,5-10-steroids
US4066757A (en) 1973-03-26 1978-01-03 Ortho Pharmaceutical Corporation Oral contraceptive regimen
DE2365103C3 (de) 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
US4147783A (en) 1974-02-28 1979-04-03 Akzona Incorporated Oral pharmaceutical preparation
DD114067A1 (de) * 1974-10-14 1975-07-12
NL7506407A (nl) 1975-05-30 1976-12-02 Akzo Nv Werkwijze ter bereiding van een oraal werkzaam far- maceutisch preparaat.
US4027019A (en) 1975-07-24 1977-05-31 Ortho Pharmaceutical Corporation 3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method
US4154820A (en) 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US4145416A (en) 1976-06-23 1979-03-20 Schering, A.G. Novel agents and novel methods for treatment of climacteric disturbances
US4292315A (en) 1977-12-30 1981-09-29 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4291028A (en) 1977-12-30 1981-09-22 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
DE2818164A1 (de) 1978-04-21 1979-10-31 Schering Ag 1,3-dibenzoesaeureester des 17alpha- ethinyl-7 alpha -methyl-1,3,5(10)-oestratrien- 1,3,17 beta -triols, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
US4756907A (en) 1978-10-17 1988-07-12 Stolle Research & Development Corp. Active/passive immunization of the internal female reproductive organs
NL8001593A (nl) 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4315925A (en) 1980-05-30 1982-02-16 University Of Kentucky Research Foundation Method of administering natural female sex hormones
US4383993A (en) 1980-05-30 1983-05-17 University Of Kentucky Research Foundation Nasal dosage forms containing natural female sex hormones
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4425339A (en) 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4512986A (en) 1983-07-26 1985-04-23 Research Triangle Institute Progrestationally active steroids
US4826831A (en) 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4544554A (en) 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4616006A (en) 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4530839A (en) 1983-09-26 1985-07-23 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4628051A (en) 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DE3347125A1 (de) 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
US5010070A (en) 1987-06-15 1991-04-23 Warner-Lambert Company Graduated estrogen contraceptive
US4962098A (en) 1987-06-15 1990-10-09 Warner-Lambert Company Graduated estrogen contraceptive
DE3505433A1 (de) 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
DE3510555A1 (de) 1985-03-21 1986-09-25 Schering AG, 1000 Berlin und 4709 Bergkamen Estriolester
US4816257A (en) 1985-09-20 1989-03-28 Research & Education Institute, Harbor-Ucla Medical Center Inc. Method for producing an in vivo environment suitable for human embryo transfer
US4764378A (en) 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US5208225A (en) 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
US4762717A (en) 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
US4816258A (en) 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
US4855305A (en) 1987-03-23 1989-08-08 Applied Medical Research Compositions and methods of effecting contraception utilizing melatonin
EP0300523B1 (de) 1987-07-06 1991-08-14 Akzo N.V. Pharmazeutische Dosierungseinheit zur Vorbeugung bzw. Behandlung von klimakterischen Beschwerden
US4900734A (en) 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
FR2623498B1 (fr) * 1987-11-24 1990-04-06 Bioprojet Soc Civ Nouveaux composes enantiomeres derives d'amino-acides, leur procede de preparation et leurs applications therapeutiques
DE3741801A1 (de) 1987-12-07 1989-06-15 Schering Ag 17-methylen-estratriene
GB8813353D0 (en) 1988-06-06 1988-07-13 Ici Plc Therapeutic product
NL8801670A (nl) 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan Farmaceutisch preparaat.
US5043331A (en) 1989-06-15 1991-08-27 Orion-Yhtyma Oy Treatment of postmenopausal disorders
US5130137A (en) 1989-08-09 1992-07-14 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders
US5098714A (en) 1989-11-16 1992-03-24 Alza Corporation Osmotic, oral dosage form for fertility control
US5200197A (en) 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
DE4104385C1 (de) 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
ZA924811B (en) 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
HU222501B1 (hu) 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
US5464871A (en) 1993-05-12 1995-11-07 Octamer, Inc. Aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents
US5210081A (en) 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
IL107343A (en) 1992-11-02 2003-10-31 Wyeth Corp PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
US5424146A (en) * 1994-10-11 1995-06-13 Cheng Kwang Storage Battery Co., Ltd. Storage battery with a battery housing that provides protection against leakage
US5759577A (en) 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5547948A (en) 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5861431A (en) 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
WO1997004752A1 (en) 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
US5998639A (en) 1995-11-06 1999-12-07 Akzo Nobel, N.V. Sulfatation of estrogen mixtures
US5807586A (en) 1996-07-30 1998-09-15 Energetics, Inc. Method of dietary supplementation
US5654011A (en) 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US6040333A (en) 1996-07-30 2000-03-21 Energetics, Inc. Dietary supplements
ID18256A (id) * 1996-09-16 1998-03-19 American Home Prod Penggunaan dari 8,9-dehidro estron sebagai estrogen dengan hasil netral pada tingkat prolaktin
EP1216713A1 (de) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Zusammensetzungen von Estrogen-Zyklodextrin Komplexe
US6630166B1 (en) * 2001-02-12 2003-10-07 Watson Pharmaceuticals, Inc. Compositions for conjugated estrogens and associated methods
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
TWI332400B (en) * 2001-12-14 2010-11-01 Solvay Pharm Gmbh Preformulation for the tableting of natural mixtures of conjugated estrogens
TWI252111B (en) * 2001-12-14 2006-04-01 Solvay Pharm Gmbh Matrix film tablet with controlled release of a natural mixture of conjugated estrogens

Also Published As

Publication number Publication date
PL1464650T3 (pl) 2011-04-29
DE602004029633D1 (de) 2010-12-02
CA2462998A1 (en) 2004-10-04
CA2462998C (en) 2008-12-09
EP1464650B1 (de) 2010-10-20
EP1464650A3 (de) 2008-05-14
EP1464650A2 (de) 2004-10-06
ES2351881T3 (es) 2011-02-11
US6992075B2 (en) 2006-01-31
US20040198670A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
ATE485302T1 (de) Neue estrogene, herstellbar durch erhitzung von konjugierten estrogenen unter erhöhter feuchtigkeit
NO20031687L (no) Veksthormonsekretagoger
DE69911637D1 (de) Verbesserte zusammensetzungen mit unkomplexiertem cyclodextrin zur geruchskontrolle
DE50202504D1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
MXPA06012500A (es) Compuestos para el tratamiento de la enfermedad de alzheimer y para la inhibicion de la produccion del peptido beta-amiloideo.
ATE370770T1 (de) Hautreinigungsmittel
BG111461A (en) TECHNICAL METHOD FOR OBTAINING TROPENOL
SE0100080L (sv) Nytt förfarande
ATE398121T1 (de) Neue synthese von irbesartan
NO20033949L (no) Sammensetning og fremgangsmåte til å behandle neoplastiske sykdommer assosiert med forhöyede matriks metalloproteinaseaktiviteter ved åbenytte katechinforbindelser
DK1446209T3 (da) Fremgangsmåde til ekstraktion af indholdsstoffer fra organisk materiale
DE502005000428D1 (de) Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen
ATE275149T1 (de) Verfahren zur herstellung von taxanderivaten
DE60137607D1 (de) Substituierte cyclohexene
FR2724944B1 (fr) Levure a permeabilite modifiee
ATE348801T1 (de) Verfahren zur herstellung von disubstituierten 9- alkylidenfluorenen und deren derivaten.
ATE282726T1 (de) Herstellung von verbindungen auf basis von cu-in- se phasengleichgewichten
ATE272038T1 (de) Verfahren zur herstellung von 2-alkyl-3- chlorphenolen
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine
BR0308753A (pt) Método para produzir pseudo-ilhotas
DE50114758D1 (de) Verfahren zur herstellung von indolen
ATE261436T1 (de) Verfahren zu herstellung von substituierten pyranen
DE50312447D1 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
DE69926651D1 (de) Verfahren zur herstellung von 2,6-dimethylnaphthalin
DE50210739D1 (de) Bedienungsanordnung zur Betätigung von Steuerorganen durch einen gemeinsamen Bedienhebel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties